Combined therapy of somatostatin analogues with pegvisomant for the treatment of acromegaly: a meta-analysis of prospective studies

Combined therapy of somatostatin analogues with pegvisomant for the treatment of acromegaly: a meta-analysis of prospective studies

Abstract Background Acromegaly is a rare, chronic and severe disease. Drug therapy including somatostatin analogues (SAs), dopamine receptor agonists and growth hormone receptor antagonists (pegvisomant, PEG) are commonly used to treat patients who do not respond to surgery. The use of combination t...

Full description

Bibliographic Details
Main Authors: Lingyun Ma, Daohuang Luo, Ting Yang, Songtao Wu, Min Li, Chaoyang Chen, Shuang Zhou, Lingyue Ma, Ye Wu, Ying Zhou, Yimin Cui
Format: Article
Language:English
Published: BMC 2020-08-01
Series:BMC Endocrine Disorders
Subjects:
Somatostatin analogues
Pegvisomant
Acromegaly
Meta-analysis
Online Access:http://link.springer.com/article/10.1186/s12902-020-0545-2

Internet

http://link.springer.com/article/10.1186/s12902-020-0545-2

Similar Items